NCT05714553 2025-07-18
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
Phase 1/2 Terminated
NuCana plc
University of Nebraska
University of California, San Francisco
Georgetown University
Roswell Park Cancer Institute
Northwestern University